companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements. Top 10 Major Shareholders(@09 May 2022) Share % 1. นาย ขรรค์ชัย บุนปาน
information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial
of revenue and cost of sales comparing to Quarter 1 in 2018 decreased as the company managed to reduce the cost of raw material to be cheaper that the same period last year. Selling and Administrative
with total revenue from medical treatment for the 1st quarter of Year 2019, equaled to 78.4% comparing to the 1st quarter of Year 2018, equaled to 63.3%. There are two main reasons of the increasing in
cost of sales comparing to Quarter 2 in 2019 decreased as the company managed to reduce the cost of raw material to be cheaper that the same period last year. Selling and Administrative Expenses For the
depreciation expenses. Net Profit The Company’s net profit in 2Q19 was Baht 13.91 million – a decrease of 67.76% when compared with that in 2Q18. Comparing with the net profit in 1Q19, net profit decreased by
5%. This is mainly because of the increased in direct labor and overhead for manufacturing costs. However, the percentage of revenue and cost of sales comparing to Quarter 2 in - 3 - 2019 decreased as
growth in sales during Q2 of last year from the transfer of one major overseas customer from a distributor to HM directly, sales of HM has decreased slightly this year comparing to the same period of last
IPD which generated highest margin comparing to other categories. Moreover, the efficient cost management such as medicine & medical supplies as well as the benefit from economy of scale in term of
Baht 40.40 million, comparing with the same period in 2017, the net loss at the amount of Bath 3.74 million. In the first quarter of 2018, the net loss was increased by Baht 36.66 million which details